100286-90-6
基本信息
伊立替康
盐酸伊立替康
盐酸依立替康
CAMPTOTHECIN 11 HYDROCHLORIDE
CAMPTOTHECIN 11 HYDROCHLORIDE,TOPOTECIN
CPT-11
IRINOTECAN HCL
IRINOTECAN HYDROCHLORIDE
(S)-4,11-DIETHYL-3,4,12,14-TETRAHYDRO-4-HYDROXY-3,14-DIOXO-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL ESTER
TOPOTECIN HYDROCHLORIDE
(1,4’-bipiperidine)-1’-carboxylicacid,3,4,12,14-tetrahydro-4,11-diethyl-4-hyd
(s)-ydrochlorid
7-ethyl-10-(4-(1-piperidino)-1-piperidino)carbonyloxycamptothecinhydrochlor
campto
roxy-3,4-dioxo-1h-pyrano(3’,4’:6,7)indolizino(1,2-b)quinolin-9-ylester,monoh
topotecin
u10144oe
[1,4Bipiperidine]-1carboxylic acid (S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[346,7]indolizino[1,2-b]quinolin-9-yl ester, Hcl Trihydrate
[1,4'-Bipiperidine]-1'-carboxylic acid, (4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester, monohydrochloride (9CI)
[1,4'-Bipiperidine]-1'-carboxylic acid, 4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester, monohydrochloride, (S)-
7-Ethyl-10-[[4-(1-piperidyl)-1-piperidyl]carbonyloxy]camptothecin hydrochloride
Camptothecin 11
物理化学性质
外观 | 淡黄色粉末或淡黄色结晶性粉末,无臭,在水、乙醇或氯仿中微溶,在丙酮中不溶。 |
熔点 | 250-256°C (dec.) |
沸点 | 257 °C |
折射率 | 67.7 ° (C=1, H2O) |
储存条件 | 2-8°C |
储存条件 | Refrigerator |
溶解度 | Soluble in DMSO or DMF at approximately 20mg/ml. Sparingly soluble in aqueous buffers. /n |
储藏 | 真空密封、避光、低温保存。 |
形态 | 黄色粉末 |
颜色 | White to yellow |
水溶解性 | Soluble in DMSO at 100mg/ml. Soluble in water at 25mg/ml with warming |
Merck | 5091 |
CAS 数据库 | 100286-90-6(CAS DataBase Reference) |
安全数据
危险性符号(GHS) | GHS07 |
警示词 | 警告 |
危险性描述 | H302 |
防范说明 | P264-P270-P301+P312a-P330-P501a |
危险品标志 | Xn |
危险类别码 | 22 |
WGK Germany | 3 |
RTECS号 | DW1060750 |
海关编码 | 29399990 |
常见问题列表
Topoisomerase I
|
Irinotecan hydrochloride is a topoisomerase I inhibitor. Irinotecan inhibits the growth of LoVo and HT-29 cells, with IC 50 s of 15.8 ± 5.1 and 5.17 ± 1.4 μM, respectively, and induces similar amounts of cleavable complexes in both in LoVo and HT-29 cells. Irinotecan suppresses the proliferation of human umbilical vein endothelial cells (HUVEC), with an IC 50 of 1.3 μM.
Irinotecan (CPT-11, 5 mg/kg) significantly inhibits the growth of tumors by intratumoral injection daily for 5 days, on two consecutive weeks in rats, and such effects also occur via continuous intraperitoneal infusion by osmotic minipump into mice. However, Irinotecan (10 mg/kg) shows no effect on the growth of tumor by i.p. Irinotecan (CPT-11, 100-300 mg/kg, i.p.) apparently suppresses tumor growth of HT-29 xenografts in athymic female mice by day 21. The two groups of Irinotecan (125 mg/kg) plus TSP-1 (10 mg/kg per day) or Irinotecan (150 mg/kg) in combination TSP-1 (20 mg/kg per day) are nearly equally effective and inhibit tumor growth 84% and 89%, respectively, and both are more effective than Irinotecan alone at doses of 250 and 300 mg/kg.
知名试剂公司产品信息
盐酸伊立替康价格(试剂级)
报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
2024/11/11 | XW1002869062 | 伊利替康 | 100286-90-6 | 50MG | 208元 |
2024/11/11 | XW1002869061 | 伊利替康 | 100286-90-6 | 250MG | 429元 |
2024/11/08 | HY-16562A | 盐酸伊立替康 Irinotecan hydrochloride | 100286-90-6 | 50mg | 650元 |